drugset / Trial / NCT00542607

Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis

NCT00542607

Phase 4 Completed 94 enrolled UCB Pharma
RandomizedCrossoverDouble-blindTreatment

Summary

No information was yet available over the effect of levocetirizine in children under 12 years. The aim of this double-blind, placebo-controlled study was to assess the efficacy and safety of levocetirizine in children from 6 to 12 years old with perennial allergic rhinitis due to house dust mites.

Timeline

Start
2002-09
Primary completion
2002-12
Completion
2002-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Levocetirizine Unknown